Isatin Derivatives with Potential Antitubercular Activities

被引:61
作者
Jiang, Dan [1 ]
Wang, Gang-Qiang [1 ]
Liu, Xiaofeng [2 ,3 ]
Zhang, Zhenbin [2 ]
Feng, Lian-Shun [4 ]
Liu, Ming-Liang [5 ,6 ]
机构
[1] Hubei Univ Sci & Technol, Sch Nucl Technol & Chem & Biol, Xianning, Peoples R China
[2] Zhejiang Xianju Junye Pharmaceut Co Ltd, Xianju 317300, Zhejiang, Peoples R China
[3] Wuhan Univ Sci & Technol, Sch Chem & Chem Engn, Wuhan 430081, Hubei, Peoples R China
[4] WuXi AppTec Wuhan, Wuhan, Hubei, Peoples R China
[5] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China
[6] Peking Union Med Coll, Beijing 100050, Peoples R China
关键词
IN-VITRO ANTIMYCOBACTERIAL; REVERSE-TRANSCRIPTASE INHIBITORS; BIOLOGICAL EVALUATION; HYBRIDS DESIGN; SCHIFF-BASES; ANTIBACTERIAL ACTIVITIES; MOLECULAR HYBRIDIZATION; ANTITUMOR-ACTIVITY; QUINOLINE HYBRIDS; MANNICH-BASES;
D O I
10.1002/jhet.3189
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Tuberculosis is a life-threatening chronic infectious disease, which primarily affects the lungs but can spread to other vital organs. The re-emergence and wide spread of new virulent forms of Mycobacterium tuberculosis that are resistant to some or all first and second line antitubercular agents has reached an alarming level in recent decades. Thus, it is imperative to develop more effective agents. Isatin derivatives are endowed with diverse biological properties, therefore thousands of isatin derivatives have been synthesized in hopes of discovering new candidates with potential antitubercular activities against both drug-susceptible and drug-resistant strains. This review summarizes the recent developments of isatin derivatives with potential antitubercular activities.
引用
收藏
页码:1263 / 1279
页数:17
相关论文
共 138 条
[1]   Synthesis and anti-mycobacterial activity of 4-(4-phenyl-1H-1,2,3-triazol-1-yl)salicylhydrazones: revitalizing an old drug [J].
Abdu-Allah, Hajjaj H. M. ;
Youssif, Bahaa G. M. ;
Abdelrahman, Mostafa H. ;
Abdel-Hamid, Mohammed K. ;
Reshma, Rudraraju Srilakshmi ;
Yogeeswari, Perumal ;
Aboul-Fadl, Tarek ;
Sriram, Dharmarajan .
ARCHIVES OF PHARMACAL RESEARCH, 2017, 40 (02) :168-179
[2]   Synthesis, antitubercular activity and pharmacokinetic studies of some Schiff bases derived from 1-alkylisatin and isonicotinic acid hydrazide (INH) [J].
Aboul-Fadl, T ;
Mohammed, FAH ;
Hassan, EAS .
ARCHIVES OF PHARMACAL RESEARCH, 2003, 26 (10) :778-784
[3]  
Aboul-Fadl T., 2015, Der Pharma Chem, V7, P217
[4]  
Aboul-Fadl T, 2012, DIG J NANOMATER BIOS, V7, P329
[5]   Schiff Bases of Indoline-2,3-dione: Potential Novel Inhibitors of Mycobacterium Tuberculosis (Mtb) DNA Gyrase [J].
Aboul-Fadl, Tarek ;
Abdel-Aziz, Hatem A. ;
Abdel-Hamid, Mohammed K. ;
Elsaman, Tilal ;
Thanassi, Jane ;
Pucci, Michael J. .
MOLECULES, 2011, 16 (09) :7864-7879
[6]   Schiff bases of indoline-2,3-dione (isatin) derivatives and nalidixic acid carbohydrazide, synthesis, antitubercular activity and pharmacophoric model building [J].
Aboul-Fadl, Tarek ;
Bin-Jubair, Fayzah A. S. ;
Aboul-Wafa, Omima .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (10) :4578-4586
[7]   New carbodithioate derivatives: synthesis, characterization, and in vitro antibacterial, antifungal, antitubercular, and antimalarial activity [J].
Akhaja, Tarunkumar Nanjibhai ;
Raval, Jignesh Priyakant .
MEDICINAL CHEMISTRY RESEARCH, 2013, 22 (10) :4700-4707
[8]   Design, synthesis and in vitro evaluation of tetrahydropyrimidine-isatin hybrids as potential antitubercular and antimalarial agents [J].
Akhaja, Tarunkumar Nanjibhai ;
Raval, Jignesh Priyakant .
CHINESE CHEMICAL LETTERS, 2012, 23 (07) :785-788
[9]   Design, synthesis, in vitro evaluation of tetrahydropyrimidine-isatin hybrids as potential antibacterial, antifungal and anti-tubercular agents [J].
Akhaja, Tarunkumar Nanjibhai ;
Raval, Jignesh Priyakant .
CHINESE CHEMICAL LETTERS, 2012, 23 (04) :446-449
[10]   1,3-dihydro-2H-indol-2-ones derivatives: Design, Synthesis, in vitro antibacterial, antifungal and antitubercular study [J].
Akhaja, Tarunkumar Nanjibhai ;
Raval, Jignesh Priyakant .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (11) :5573-5579